BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30788714)

  • 1. Influence of Neoadjuvant Radiation Dose on Patients Undergoing Esophagectomy and Survival in Locally Advanced Esophageal Cancer.
    Ising MS; Marino K; Trivedi JR; Rojan AA; Dunlap NE; van Berkel V; Fox MP
    J Gastrointest Surg; 2019 Apr; 23(4):670-678. PubMed ID: 30788714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer.
    Ji KSY; Thomas SM; Roman SA; Czito B; Anderson KL; Frakes J; Adam MA; Sosa JA; Robinson TJ
    J Gastrointest Surg; 2019 May; 23(5):885-894. PubMed ID: 30374818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy.
    Depypere L; Thomas M; Moons J; Coosemans W; Lerut T; Prenen H; Haustermans K; Van Veer H; Nafteux P
    World J Surg Oncol; 2019 May; 17(1):89. PubMed ID: 31133018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
    Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
    J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
    Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
    Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Neoadjuvant Radiation Dose on Surgical and Oncological Outcome in Locally Advanced Esophageal Cancer.
    Van Daele E; Ceelen W; Boterberg T; Varinl O; Van Nieuwenhove Y; Putte DV; Geboes K; Pattyn P
    Acta Chir Belg; 2015 Jan; 115(1):8-14. PubMed ID: 27384890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.
    Valencia Julve J; Alonso Orduña V; Escó Barón R; López-Mata M; Méndez Villamón A
    Clin Transl Oncol; 2006 Jan; 8(1):22-30. PubMed ID: 16632436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.
    Vlacich G; Samson PP; Perkins SM; Roach MC; Parikh PJ; Bradley JD; Lockhart AC; Puri V; Meyers BF; Kozower B; Robinson CG
    Cancer Med; 2017 Dec; 6(12):2886-2896. PubMed ID: 29139215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.
    Buckstein M; Rhome R; Ru M; Moshier E
    Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29309563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
    Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
    Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.
    Cao XF; He XT; Ji L; Xiao J; Lv J
    Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
    Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
    J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008.
    Worni M; Martin J; Gloor B; Pietrobon R; D'Amico TA; Akushevich I; Berry MF
    J Am Coll Surg; 2012 Nov; 215(5):643-51. PubMed ID: 23084493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation With Neoadjuvant Chemotherapy Does Not Improve Outcomes in Esophageal Squamous Cell Cancer.
    Miller JA; Groman A; Yendamuri S; Hennon M
    J Surg Res; 2019 Apr; 236():259-265. PubMed ID: 30694764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation field size and dose determine oncologic outcome in esophageal cancer.
    Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A
    World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher Doses of Neoadjuvant Radiation for Esophageal Cancer Do Not Affect the Pathologic Complete Response Rate or Survival: A Propensity-Matched Analysis.
    Worrell SG; Towe CW; A Dorth J; Machtay M; Perry Y; Linden PA
    Ann Surg Oncol; 2020 Feb; 27(2):500-508. PubMed ID: 31571054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
    Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
    Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
    Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.